Author

L. G. A. McKay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:protein structure· 1

Frequent Co-Authors

A. Griffiths· 3 shared R. I. Johnson· 3 shared N. Storm· 2 shared A. Coscia· 1 shared A. N. Honko· 1 shared A. Polley· 1 shared B. C. Heimbach· 1 shared B. Chen· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. Griffiths

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 18, 2021

Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody Cocktail

P. A. Nikitin, J. M. DiMuzio, J. P. Dowling…·M. K. Robinson

The paper identifies and characterizes an antibody cocktail, IMM-BCP-01, that neutralizes SARS-CoV-2 variants in vitro and inhibits infection in vivo through Spike Trimer dissociation and effector responses.

DOI 10.1101/2021.10.18.464900

mouseproteomics

𝕏 PostBluesky

MicrobiologyNature Structural & Molecular BiologyPeer-reviewedFeb 1, 2021

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro

T. Xiao, J. Lu, J. Zhang…·B. Chen

This study creates a trimeric ACE2 variant with high affinity for SARS-CoV-2 spike protein and shows it inhibits viral infection in cell culture.

DOI 10.1038/s41594-020-00549-3

humanprotein structure

𝕏 PostBluesky

MicrobiologybioRxivNov 13, 2020

Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2

S. A. Clark, L. E. Clark, J. Pan…·J. Abraham

The paper identifies germline-biased neutralizing antibodies against SARS-CoV-2 and shows that affinity gains do not always correlate with neutralization potency.

DOI 10.1016/j.cell.2021.03.027

humanproteomics

𝕏 PostBluesky